Personalising doses of semaglutide The real-world cohort study involved 2,246 individuals in Denmark (79% female, median age 49 years, median BMI of 33.2, median body weight 97kg/15st 4lb) who were enrolled in a weight management programme run through the Embla app, available in Denmark and in the UK
Common (Oral): Gastrointestinal disturbance, diarrhea, nausea, vomiting, fatigue, conjunctival irritation, skin rash (26) (28) Other: Hypotension, anaphylaxis, asthma attacks, headache (29) Case reports Photosensitivity not attributable to location, season, or concomitant medication: Occurred among pulmonary fibrosis patients more frequently with acetylcysteine than placebo in combination with pirfenidone (39)
This effect was attributed to the peptide's ability to elevate GH levels and stimulate appetite [19]
The physicians role is to evaluate whether the medication makes sense and how to use it safely